Analyze Diet
Animals : an open access journal from MDPI2019; 9(8); doi: 10.3390/ani9080585

Clinical Effects of the Extract of the Seeds of the Indian Celery-Apium Graveolens-In Horses Affected by Chronic Osteoarthritis.

Abstract: The extract of the seeds from Indian celery, Apium greaveolens (CSE), tested in experimental animals (rodents), and in humans affected by chronic osteoarthritic diseases, exhibits anti-inflammatory effects that can be compared, to some degree, to those of non-steroid anti-inflammatory drugs (NSAID). In view of a potential use of CSE in the equine species, it was tested on horses affected by chronic articular pathologies. The trial was performed on 20 horses divided into three different groups, orally treated with 0 (controls), 7.0 or 30 g of CSE BID. Basic orthopedic examinations were conducted, vital signs were observed, and blood samples collected. Improvement was observed at the highest dosage tested (30 g of CSE BID), as reflected in the score values of three clinical parameters, (i) amplitude and (ii) sensitivity to passive flexion and (iii) flexion test. Since the improvement of these parameters can be correlated with a lower perception of the pain, the present data suggest that the CSE treatment can have an analgesic effect in horses affected by chronic osteoarthritic diseases.
Publication Date: 2019-08-20 PubMed ID: 31434330PubMed Central: PMC6720213DOI: 10.3390/ani9080585Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the effect of Indian Celery Seed Extract (CSE) on horses with chronic osteoarthritis, suggesting that large doses might significantly aid in pain management similar to non-steroidal anti-inflammatory drugs (NSAIDs).

Objective of the Research

  • The research aims to delve into the potential use of Indian Celery Seed Extract (CSE), already known for its anti-inflammatory effects in rodents and humans, for treating chronic joint diseases in horses.

Methodology

  • A total of 20 horses with persistent joint afflictions were split into three different groups. They were given oral doses of either 0 (control group), 7.0, or 30 grams of CSE twice a day.
  • Fundamental orthopedic examinations were conducted, and the horses’ vital signs were observed along with the collection of blood samples for analysis.

Findings

  • The researchers observed a measurable improvement in the group administered the highest dosage of CSE (30 grams, twice daily).
  • This improvement was observed in the amplitude and sensitivity to passive flexion, along with the optional flexion test results. These parameters significantly relate to the perception of pain, and their improvement suggests reduced discomfort in the horses.

Conclusion

  • The study concludes that CSE treatment might have considerable analgesic (pain-relieving) effect in horses suffering from chronic osteoarthritic diseases, similar to the effects of NSAIDs in human treatments. This finding may forward new possibilities for more natural and less invasive treatment for equine chronic osteoarthritis. However, further research is needed to verify the results and calculate the optimal dosages.

Cite This Article

APA
Battaglia B, Angelone M, Vera E, Basini G, Bussolati S, Paci M, Bue MD, Aldigeri R, Grolli S, Quintavalla F, Ramoni R. (2019). Clinical Effects of the Extract of the Seeds of the Indian Celery-Apium Graveolens-In Horses Affected by Chronic Osteoarthritis. Animals (Basel), 9(8). https://doi.org/10.3390/ani9080585

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 9
Issue: 8

Researcher Affiliations

Battaglia, Beatrice
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Angelone, Mario
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Vera, Elena
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Basini, Giuseppina
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Bussolati, Simona
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Paci, Massimiliano
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Bue, Maurizio Del
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Aldigeri, Raffaella
  • Dipartimento di Medicina e Chirurgia, Università di Parma, Via Gramsci 14, 43126 Parma, Italy.
Grolli, Stefano
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Quintavalla, Fausto
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy.
Ramoni, Roberto
  • Dipartimento Scienze Medico Veterinarie, Università di Parma, Via del taglio 10, 43126 Parma, Italy. roberto.ramoni@unipr.it.

Grant Funding

  • Ramoni - Ric. dipartimentale 2014-70% / Dipartimento di Scienze Medico-Veterinarie, Università di Parma

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 28 references
  1. Caron J.P., Genovese R.L.. Principles and practices of joint disease treatment.. .
  2. Goldring S.R., Goldring M.B.. Clinical aspects, pathology and pathophysiology of osteoarthritis.. J. Musculoskelet. Neuronal Interact. 2006;6:376–378.
    pubmed: 17185832
  3. Curtiss J., Paul H.. The pathophysiology of joint infections.. Clin. Orthop. Relat. Res. 1973;96:129–135.
  4. Brandt K.D., Dieppe P., Radin E.L.. Etiopathogenesis of osteoarthritis.. Med. Clin. N. Am. 2009;93:1–24.
    doi: 10.1016/j.mcna.2008.08.009pubmed: 19059018google scholar: lookup
  5. Goodrich L.R., Nixon A.J.. Medical treatment of osteoarthritis in the horse: A review.. Vet. J. 2006;171:51–69.
    doi: 10.1016/j.tvjl.2004.07.008pubmed: 16427582google scholar: lookup
  6. Chevallier A.. The Encyclopedia of Medicinal Plant.. 1996.
  7. Gaby A.R.. Natural treatments for osteoarthritis.. Altern. Med. Rev. 1999;4:330–341.
    pubmed: 10559548
  8. Trumble T.N.. The use of nutraceuticals for osteoarthritis in horses.. Vet. Clin. N. Am. Equine Pract. 2005;21:575–597.
    doi: 10.1016/j.cveq.2005.08.004pubmed: 16297722google scholar: lookup
  9. McIlwraith C.W., Frisbie D.D., Kawcak C.E.. The horse as a model of naturally occurring osteoarthritis.. Bone Joint Res. 2012;1:297–309.
  10. Powanda M.C., Rainsford K.D.. A toxicological investigation of a celery seed extract having anti-inflammatory activity.. Inflammopharmacology 2011;19:227–233.
    doi: 10.1007/s10787-010-0049-1pubmed: 20568016google scholar: lookup
  11. Whitehouse M.W., Roberts M.S., Brooks P.M.. Over the counter (OTC) oral remedies for arthritis and rheumatism: How effective are they?. Inflammopharmacology 1999;7:89–105.
    doi: 10.1007/BF02918382pubmed: 18597151google scholar: lookup
  12. Zhu L.H., Bao T.H., Deng Y., Li H., Chen L.X.. Constituents from Apium graveolens and their anti-inflammatory effects.. J. Asian Nat. Prod. Res. 2017;19:1079–1086.
    doi: 10.1080/10286020.2017.1381687pubmed: 28971709google scholar: lookup
  13. Sowbhagya H.B.. Chemistry, Technology, and Nutraceutical Functions of Celery (Apium graveolens L.) An Overview.. Crit. Rev. Food Sci. Nutr. 2014;54:389–398.
    doi: 10.1080/10408398.2011.586740pubmed: 24188309google scholar: lookup
  14. Whitehouse M.W., Butters D.E., Clarcke M.L., Rainsford K.D.. NSAID gastropathy: Prevention by celery seed extracts in disease-stressed rats.. Inflammopharmacology 2001;1:201–209.
  15. Kester W.O.. Guide for Veterinary Services and Judging of Equestrian Events.. 1991.
  16. MacAllister C.G., Morgan S.J., Borne A.T., Pollet R.A.. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.. J. Am. Vet. Med. Assoc. 1993;202:71–77.
    pubmed: 8420909
  17. Noble G., Edwards S., Lievaart J., Pippia J., Boston R., Raidal S.L.. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.. J. Vet. Intern. Med. 2012;5:1192–1201.
  18. Tamzali Y., Guelfi J.F., Braun J.P.. Plasma fibrinogen measurement in the horse: Comparison of Millar’s technique with a chronometric technique and the QBC-Vet Autoreader™.. Res. Vet. Sci. 2001;71:213–217.
    doi: 10.1053/rvsc.2001.0513pubmed: 11798297google scholar: lookup
  19. Crisman M.V., Scarratt W.K., Zimmerman K.L.. Blood proteins and inflammation in the horse.. Vet. Clin. N. Am. Equine Pract. 2008;4:285–297.
    doi: 10.1016/j.cveq.2008.03.004pubmed: 18652956google scholar: lookup
  20. Borges A.S., Divers T.J., Stokol T., Mohammed O.H.. Serum iron and plasma fibrinogen concentrations as indicators of systemic inflammatory diseases in horses.. J. Vet. Intern. Med. 2007;21:489–494.
  21. Kusano K., Yamasaki M., Kiuchi M., Kaneko K., Koyama K.. Reference range of blood biomarkers for oxidative stress in Thoroughbred racehorses (2–5 years old). J. Equine Sci. 2016;27:125–129.
    doi: 10.1294/jes.27.125pmc: PMC5048360pubmed: 27703408google scholar: lookup
  22. Benzie I.F.F., Strain J.J.. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power: The FRAP assay”.. Anal. Biochem. 1996;2391:70–76.
    doi: 10.1006/abio.1996.0292pubmed: 8660627google scholar: lookup
  23. Baxter G.M.. Adams and Stashak’s Lameness in Horses.. 2011.
  24. Blumenthal M., Busse W.R., Goldberg A., Gruenwald J., Hall T., Riggins C.W., Klein S., Rister R.S.. The Complete German Commission E Monographs—Therapeutic Guide to Herbal Medicines.. 1998.
  25. De Grauw J.C., Van De Lest C.H., Van Weeren R., Brommer H., Brama P.A.. Arthrogenic lameness of the fetlock: Synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain.. Equine Vet. J. 2006;38:305–311.
    doi: 10.2746/042516406777749236pubmed: 16866196google scholar: lookup
  26. Beluche L.A., Bertone A.L., Anderson D.E., Rohde C.. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism.. Am. J. Vet. Res. 2001;62:1916–1921.
    doi: 10.2460/ajvr.2001.62.1916pubmed: 11763181google scholar: lookup
  27. Momin R.A., Nair M.G.. Antioxidant, cyclooxygenase and topoisomerase inhibitory compounds from Apium graveolens Linn. Seeds.. Phytomedicine. 2002;9:312–318.
    doi: 10.1078/0944-7113-00131pubmed: 12120812google scholar: lookup
  28. Mencherini T., Cau A., Bianco G., Della Loggia R., Aquino R.P., Autore G.. An extract of Apium graveolens var. dulce leaves: Structure of the major constituent, apiin and its anti-inflammatory properties.. J. Pharm. Pharmacol. 2007;59:891–897.
    doi: 10.1211/jpp.59.6.0016pubmed: 17637182google scholar: lookup

Citations

This article has been cited 1 times.
  1. Tonelli A, Mangia V, Candiani A, Pasquali F, Mangiaracina TJ, Grazioli A, Sozzi M, Gorni D, Bussolati S, Cucinotta A, Basini G, Selleri S. Sensing Optimum in the Raw: Leveraging the Raw-Data Imaging Capabilities of Raspberry Pi for Diagnostics Applications. Sensors (Basel) 2021 May 20;21(10).
    doi: 10.3390/s21103552pubmed: 34065190google scholar: lookup